Elite Pharmaceuticals (ELTP) Times Interest Earned (2010 - 2026)
Elite Pharmaceuticals' (ELTP) Times Interest Earned was 103.00 for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 24.6% from 136.54 a year earlier.
Powered by 
Analysis
Elite Pharmaceuticals (ELTP) Times Interest Earned (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Elite Pharmaceuticals' Times Interest Earned came in at 69.42, up 26.2% year-over-year; for FY2026 (ended Mar 31, 2026), it was 123.82, up 387.9% from FY2025.
- Times Interest Earned has increased for three consecutive fiscal years.
- By fiscal year, Times Interest Earned came in at 25.38 in FY2025 (+38.5%), 18.33 in FY2024 (+454.8%), 3.30 in FY2023 (-87.5%) and 26.44 in FY2022 (+226.1%).
- Five-year quarterly Times Interest Earned spans a low of -1.17 in fiscal Q4 2023 and a high of 136.54 in fiscal Q1 2026.
- Year over year, Times Interest Earned gained in three of the last six quarters, with growth averaging 262.7%.
- The high point for year-over-year Times Interest Earned in five years was fiscal Q1 2026 (growth of 786.2%); the low point was fiscal Q3 2023 (a decline of 87.6%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 25.41 |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | - |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 10.28 |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 7.27 |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 5.22 |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -42.08 |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | - |
| 10 | Elite Pharmaceuticals | 268.12 Mn | 149.80 Mn | 13.51 Mn | 103.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 103.00 |
| Sep 30, 2025 | 99.60 |
| Jun 30, 2025 | 136.54 |
| Mar 31, 2025 | 59.06 |
| Dec 31, 2024 | 14.15 |
| Sep 30, 2024 | 13.66 |
| Jun 30, 2024 | 15.41 |
| Mar 31, 2024 | 17.17 |
| Dec 31, 2023 | 29.04 |
| Sep 30, 2023 | 14.76 |
| Jun 30, 2023 | 13.42 |
| Mar 31, 2023 | -1.17 |
| Dec 31, 2022 | 6.07 |
| Sep 30, 2022 | 4.45 |
| Jun 30, 2022 | 4.72 |
| Mar 31, 2022 | 13.01 |
| Dec 31, 2021 | 48.97 |
| Sep 30, 2021 | 33.02 |
| Jun 30, 2021 | 21.03 |
| Mar 31, 2021 | -51.47 |
API Access
Elite Pharmaceuticals Times Interest Earned API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=times-interest-earned&ticker=ELTP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "times-interest-earned", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=times-interest-earned&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();